BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38095639)

  • 21. XIAP associated factor 1 (XAF1) represses expression of X-linked inhibitor of apoptosis protein (XIAP) and regulates invasion, cell cycle, apoptosis, and cisplatin sensitivity of ovarian carcinoma cells.
    Zhao WJ; Deng BY; Wang XM; Miao Y; Wang JN
    Asian Pac J Cancer Prev; 2015; 16(6):2453-8. PubMed ID: 25824780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. XAF1 drives apoptotic switch of endoplasmic reticulum stress response through destabilization of GRP78 and CHIP.
    Lee KW; Hong HR; Lim JS; Ko KP; Lee MG; Chi SG
    Cell Death Dis; 2022 Jul; 13(7):655. PubMed ID: 35902580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TOLLIP-mediated autophagic degradation pathway links the VCP-TMEM63A-DERL1 signaling axis to triple-negative breast cancer progression.
    Zhang TM; Liao L; Yang SY; Huang MY; Zhang YL; Deng L; Hu SY; Yang F; Zhang FL; Shao ZM; Li DQ
    Autophagy; 2023 Mar; 19(3):805-821. PubMed ID: 35920704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor suppressor XAF1 induces apoptosis, inhibits angiogenesis and inhibits tumor growth in hepatocellular carcinoma.
    Zhu LM; Shi DM; Dai Q; Cheng XJ; Yao WY; Sun PH; Ding Y; Qiao MM; Wu YL; Jiang SH; Tu SP
    Oncotarget; 2014 Jul; 5(14):5403-15. PubMed ID: 24980821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of expression of XIAP-associated factor 1 (XAF1) with clinicopathologic factors, overall survival, microvessel density and cisplatin-resistance in ovarian cancer.
    Wang Y; Mao H; Hao Q; Wang Y; Yang Y; Shen L; Huang S; Liu P
    Regul Pept; 2012 Oct; 178(1-3):36-42. PubMed ID: 22759793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of X‑linked inhibitor of apoptosis‑associated factor‑1 in vasculogenic mimicry in ovarian cancer.
    Wang Y; Liu P; Wang X; Mao H
    Mol Med Rep; 2017 Jul; 16(1):325-330. PubMed ID: 28534973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low expression of XIAP-associated factor 1 in human colorectal cancers.
    Ma TL; Ni PH; Zhong J; Tan JH; Qiao MM; Jiang SH
    Chin J Dig Dis; 2005; 6(1):10-4. PubMed ID: 15667552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. XIAP-associated factor 1 (XAF1), a novel target of p53, enhances p53-mediated apoptosis via post-translational modification.
    Zou B; Chim CS; Pang R; Zeng H; Dai Y; Zhang R; Lam CS; Tan VP; Hung IF; Lan HY; Wong BC
    Mol Carcinog; 2012 May; 51(5):422-32. PubMed ID: 21678496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancer.
    Kempkensteffen C; Fritzsche FR; Johannsen M; Weikert S; Hinz S; Dietel M; Riener MO; Moch H; Jung K; Krause H; Miller K; Kristiansen G
    BMC Cancer; 2009 Aug; 9():276. PubMed ID: 19664236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Negative regulation of the RLH signaling by the E3 ubiquitin ligase RNF114.
    Lin B; Ke Q; Li H; Pheifer NS; Velliquette DC; Leaman DW
    Cytokine; 2017 Nov; 99():186-193. PubMed ID: 28625874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. XAF1 mRNA expression improves progression-free and overall survival for patients with advanced bladder cancer treated with neoadjuvant chemotherapy.
    Pinho MB; Costas F; Sellos J; Dienstmann R; Andrade PB; Herchenhorn D; Peixoto FA; Santos VO; Small IA; Guimarães DP; Ferreira CG
    Urol Oncol; 2009; 27(4):382-90. PubMed ID: 18555708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitization of colorectal cancer cells to irinotecan by the Survivin inhibitor LLP3 depends on XAF1 proficiency in the context of mutated p53.
    Steigerwald C; Rasenberger B; Christmann M; Tomicic MT
    Arch Toxicol; 2018 Aug; 92(8):2645-2648. PubMed ID: 29947891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-gamma induces X-linked inhibitor of apoptosis-associated factor-1 and Noxa expression and potentiates human vascular smooth muscle cell apoptosis by STAT3 activation.
    Bai Y; Ahmad U; Wang Y; Li JH; Choy JC; Kim RW; Kirkiles-Smith N; Maher SE; Karras JG; Bennett CF; Bothwell AL; Pober JS; Tellides G
    J Biol Chem; 2008 Mar; 283(11):6832-42. PubMed ID: 18192275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. XAF1 as a prognostic biomarker and therapeutic target in squamous cell lung cancer.
    Chen YB; Shu J; Yang WT; Shi L; Guo XF; Wang FG; Qian YY
    Chin Med J (Engl); 2011 Oct; 124(20):3238-43. PubMed ID: 22088514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel splice variant of XIAP-associated factor 1 (XAF1) is expressed in peripheral blood containing gastric cancer-derived circulating tumor cells.
    Hatakeyama K; Yamakawa Y; Fukuda Y; Ohshima K; Wakabayashi-Nakao K; Sakura N; Tanizawa Y; Kinugasa Y; Yamaguchi K; Terashima M; Mochizuki T
    Gastric Cancer; 2015 Oct; 18(4):751-61. PubMed ID: 25216542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear VCP drives colorectal cancer progression by promoting fatty acid oxidation.
    Huang Y; Wang F; Lin X; Li Q; Lu Y; Zhang J; Shen X; Tan J; Qin Z; Chen J; Chen X; Pan G; Wang X; Zeng Y; Yang S; Liu J; Xing F; Li K; Zhang H
    Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2221653120. PubMed ID: 37788309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Switch to full-length of XAF1 mRNA expression in prostate cancer cells by the DNA methylation inhibitor.
    Fang X; Liu Z; Fan Y; Zheng C; Nilson S; Egevad L; Ekman P; Xu D
    Int J Cancer; 2006 May; 118(10):2485-9. PubMed ID: 16353137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. USP7 and VCP
    Franz A; Valledor P; Ubieto-Capella P; Pilger D; Galarreta A; Lafarga V; Fernández-Llorente A; de la Vega-Barranco G; den Brave F; Hoppe T; Fernandez-Capetillo O; Lecona E
    Cell Rep; 2021 Oct; 37(2):109819. PubMed ID: 34644576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. X-linked inhibitor of apoptosis-associated factor l (XAFl) enhances the sensitivity of colorectal cancer cells to cisplatin.
    Ju WC; Huang GB; Luo XY; Ren WH; Zheng DQ; Chen PJ; Lou YF; Li B
    Med Oncol; 2014 Dec; 31(12):273. PubMed ID: 25367849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. XAF1 Protects Host against Emerging RNA Viruses by Stabilizing IRF1-Dependent Antiviral Immunity.
    Han Y; Bai X; Liu S; Zhu J; Zhang F; Xie L; Liu G; Jiang X; Zhang M; Huang Y; Wang J; Li D; Zhang H; He Y; He S; Xia Y; Xu X; Xu F; Ma F
    J Virol; 2022 Sep; 96(17):e0077422. PubMed ID: 35972291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.